(Pharmamar) PharmaMar (PHM:MSE) has announced that PM1183 (lurbinectedin), its third molecule of marine origin and analogue of Yondelis®, will receive the trade name of Zepsyre.
############
Story Source: Materials provided by Scienmag
PharmaMar will commercialize PM1183 with the trade name of Zepsyre
Please login to join discussion
POPULAR NEWS
-
Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission
-
New Study Reveals the Science Behind Exercise and Weight Loss
-
New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases
-
Revolutionizing Optimization: Deep Learning for Complex Systems